...
首页> 外文期刊>Journal of magnetic resonance imaging: JMRI >Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
【24h】

Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.

机译:猪肝脏射频消融后消融区域的显着性:细胞外和SPIO造影剂的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To compare conspicuity of zones of ablation on nonenhanced, gadopentetate dimeglumine-(Gd-DTPA) and ferucarbotran-(SPIO)-enhanced magnetic resonance (MR) images. MATERIALS AND METHODS: In all, 33 radiofrequency ablations (RFA) were performed in 17 healthy porcine livers at 1.5T MR imaging 1 day and 2 and 4 weeks after RFA: T2-weighted (w) ultra turbo spin echo (UTSE), proton density (PD)-w UTSE, T1-w gradient echo (GRE) pre- and 5 minutes postcontrast administration, dynamic T1-w GRE during Gd-DTPA (Magnevist) or SPIO (Resovist) administration, T2-w UTSE, and PD-w UTSE sequences 10 minutes after SPIO administration. Regions of interest (ROIs) for contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR) were drawn in consensus by two radiologists. RESULTS: PD-w SPIO-enhanced images (23.5 +/- 5.5) showed higher liver-to-lesion CNR than T1-w GRE Gd-DTPA-enhanced images (13.5 +/- 6.1) 1 day after RFA (P < or = 0.05). At all other timepoints, liver-to-lesion CNR of PD-w and T2-w SPIO-enhanced images did not differ significantly from T1-w GRE Gd-DTPA-enhanced images (P > or = 0.05). Nonenhanced T2-w images revealed lower liver-to-lesion CNR (7.0 +/- 7.5/6.5 +/- 5.9/6.8 +/- 5.0, 1 day/2 weeks/4 weeks, respectively) than T2-w SPIO-enhanced (17.4 +/- 4.8/15.3 +/- 4.5/14.2 +/- 5.7), PD-w SPIO-enhanced (23.5 +/- 5.5/16.9 +/- 3.6, 1 day/2 weeks), and T1-w Gd-DTPA-enhanced (15.3 +/- 3.6/12.7 +/- 3.5, 2/4 weeks) images (P < or = 0.05). Liver-to-lesion CNR of SPIO-enhanced dynamic T1-w GRE images after 30, 80, 150, and 240 seconds did not change significantly over time (P > or = 0.05). CONCLUSION: One day after RFA lesion conspicuity on PD-w ferucarbotran-enhanced images is better than on T1-w GRE Gd-DTPA-enhanced images. At all other timepoints, ferucarbotran is not superior to gadolinium. Ferucarbotran- and gadolinium-enhanced images improve lesion conspicuity compared with nonenhanced T2-w images at all timepoints.
机译:用途:比较消融区在非增强,pent戊二酸二聚丁二胺(Gd-DTPA)和阿魏卡伯坦(SPIO)增强磁共振(MR)图像上的显着性。材料与方法:总共在17头健康的猪肝脏中进行了33次射频消融(RFA),射频消融后1天,2天和4周以1.5T MR成像:T2加权(w)超涡轮自旋回波(UTSE),质子密度(PD)-w UTSE,造影剂给药前后的T1-w梯度回波(GRE),Gd-DTPA(Magnevist)或SPIO(Resovist)给药期间的动态T1-w GRE,T2-w UTSE和PD -w UTSE序列在SPIO管理后10分钟执行。两位放射线医师一致地绘制了感兴趣区域(ROI)的对比度和噪声比(CNR)和信噪比(SNR)。结果:RFA后1天,PD-w SPIO增强图像(23.5 +/- 5.5)显示的肝脏至病变CNR高于T1-w GRE Gd-DTPA增强图像(13.5 +/- 6.1)(P <或= 0.05)。在所有其他时间点,PD-w和T2-w SPIO增强图像的肝脏至病变CNR与T1-w GRE Gd-DTPA增强图像无显着差异(P>或= 0.05)。未增强的T2-w图像显示,与增强TIO2的SPIO相比,肝损CNR较低(分别为7.0 +/- 7.5 / 6.5 +/- 5.9 / 6.8 +/- 5.0、1天/ 2周/ 4周) (17.4 +/- 4.8 / 15.3 +/- 4.5 / 14.2 +/- 5.7),PD-w SPIO增强(23.5 +/- 5.5 / 16.9 +/- 3.6、1天/ 2周)和T1-w Gd-DTPA增强(15.3 +/- 3.6 / 12.7 +/- 3.5,2/4周)图像(P <或= 0.05)。在30、80、150和240秒后,SPIO增强的动态T1-w GRE图像的肝脏-病变CNR随时间变化不明显(P>或= 0.05)。结论:在RFA病变后的一天,PD-w阿魏卡伯坦增强的图像明显优于T1-w GRE Gd-DTPA增强的图像。在所有其他时间点上,ferucarbotran都不优于superior。在所有时间点,与未增强的T2-w图像相比,Ferucarbotran和g增强的图像可改善病变的明显性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号